Mr. Landry has served as a member of our board of directors since August 2025. Mr. Landry brings more than 30 years of global financial leadership experience across the pharmaceutical and biotechnology sectors. Most recently, he served as Chief Financial Officer and Executive Vice President, Finance at Regeneron Pharmaceuticals Inc. Prior to Regeneron, Mr. Landry spent over two decades at Wyeth and Pfizer, Inc., where he held various senior financial leadership roles, including Senior Vice President and Treasurer at Pfizer and Chief Financial Officer of Wyeth’s Research and Development division. He currently serves on the Board of GanD, Inc. and Cytokinetics, Incorporated where he serves as a member of the Audit Committee. Mr. Landry received his Bachelor of Business Administration from the University of Notre Dame.